Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Award

OrboGraph Awarded AI Excellence Award by the Business Intelligence Group for Innovations in Check Fraud Detection


OrboGraph, a premier supplier of check processing automation and fraud detection software and services, has won the prestigious AI Excellence Award in the Hybrid Intelligent Systems category for significant contributions to enhancing check fraud detection capabilities through its integrations to leverage consortium data from Advanced Fraud Solutions (AFS) TrueChecks®, along with the ThreatAdvice dark web monitoring service called Dark Defend. This is the third consecutive year that OrboGraph has won this award.

OrboGraph has been at the forefront of combating the surge in check fraud, which has seen a 3-4X increase from pre-pandemic levels. Leveraging OrbNet Forensic AI technology, the OrboGraph OrboAnywhere suite has achieved remarkable success, boasting detection rates as high as 95%+ on counterfeits, forgeries, and alterations.

The nomination for this award was based on OrboGraph's significant advancements over the past year in providing financial institutions with enhancements in check fraud detection features and analyzers. The OrboGraph partnership with ThreatAdvice and AFS as part of the OrboAnywhere Sherlock 5.3 release provides the most robust combination of image forensics blended with positive and negative consortium data.

Barry Cohen, CEO of OrboGraph, expressed his enthusiasm about the award: "We are honored to again receive the AI Excellence Award ? Hybrid Intelligent System. This recognition is a testament to our team's hard work, innovation, and unwavering dedication to combating check fraud."

Joe Gregory, Chief Strategy Officer of OrboGraph, also shared his insights: "The challenge of check fraud is evolving, and there is no silver bullet solution. Creating a consortium connector to multiple vendors like ThreatAdvice and Advanced Fraud Solutions has allowed us to leverage a wealth of data and cast a more holistic, wider net to detect on-us and deposit check fraud transactions."

For more information, please contact James Bi at [email protected].

About OrboGraph

OrboGraph LLC. and OrboGraph LTD. (www.orbograph.com) are independent companies within the Thompson Street Capital Partners portfolio. OrboGraph is a premier developer and supplier of recognition solutions, payment negotiability, and check fraud detection for the check processing market. Nearly 4,000 financial institutions, service bureaus, and clearinghouses rely on OrboGraph technology to process billions of checks and payments annually.


These press releases may also interest you

at 00:45
Claudio Bono, Managing Director for two independent Hotels in Silicon Valley, is thrilled to unveil a groundbreaking platform and an idea that will transform the landscape of the urgent unhoused crisis and social issues. Leveraging his extensive...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: